<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02578784</url>
  </required_header>
  <id_info>
    <org_study_id>EKSG 15/086</org_study_id>
    <nct_id>NCT02578784</nct_id>
  </id_info>
  <brief_title>DEB-after-Cutting Balloon-PTA in Dialysis Fistula Stenosis</brief_title>
  <acronym>DEB-after-CB</acronym>
  <official_title>Prospective, Randomized Trial on the Clinical Utility of Drug-coated Balloons After Angioplasty of Plain Old Balloon-resistent Dialysis Fistula Stenosis Using Cutting Ballons</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cantonal Hospital of St. Gallen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of hemodynamically relevant dialysis fistula stenoses/obstructions after 1 year
      is between 60-90% (from 62.5 to 91% radiocephalic, brachiocephalic 70-84%, PTFE shunts
      62-87%), necessitating a therapeutic measure to preserve dialysis access during this period
      in 1/3 of the patients. This therapeutic measure is a dilatation of the stenosis using a
      standard PTA balloon (POBA, plain old balloon angioplasty with a primary technical success
      rate of 50-79% [2-4].In turn, in 21-50% of the cases an insufficient PTA result is obtained
      (so-called POBA-resistant stenosis). In these cases, predilatation with a so-called cutting
      balloon (carrying with small knives on its surface) is performed, leading to a success rate
      of 89%. However, a problem is the high incidence of restenosis, which is about 40% for
      recurrent stenosis and over 10% in de novo stenosis.

      The use of drug-coated balloon (DCB) in non-POBA resistant stenoses lead to a reduction in
      the restenosis rate of 35% to 5%. However, the effect of DCB in POBA resistant stenoses is
      unknown.

      Therefore, the aim of this study is to evaluate the clinical benefit of the combined use of a
      cutting balloon and a drug-coated balloon in POBA resistant dialysis fistula stenoses
      compared to the sole use of a cutting balloon.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to worsening of dialysis fistula function [days]</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in lumen 12 months after PTA [mm]</measure>
    <time_frame>one year</time_frame>
    <description>aka &quot;late lumen loss&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dialysis flow [ml/min.]</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dialysis fistula flow [ml/min.]</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>POBA-after-Cutting Balloon</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After cutting balloon angioplasty, subsequent angioplasty is performed using a standard, non-coated balloon (plain old balloon, POBA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DCB-after-Cutting Balloon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After cutting balloon angioplasty, subsequent angioplasty is performed using a drug-coated balloon (DCB)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angioplasty with drug-coated balloon</intervention_name>
    <description>Angioplasty with drug-coated balloon &quot;Elutax&quot; (Aachen Resonance, Germany)</description>
    <arm_group_label>DCB-after-Cutting Balloon</arm_group_label>
    <other_name>drug-coated balloon &quot;Elutax&quot;</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angioplasty with plain old balloon</intervention_name>
    <description>Angioplasty with plain old balloon &quot;Sterling&quot; (BostonScientific, Switzerland)</description>
    <arm_group_label>POBA-after-Cutting Balloon</arm_group_label>
    <other_name>balloon &quot;Sterling&quot;</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  dialysis fistula dysfunction requiring cutting balloon angioplasty

        Exclusion Criteria:

          -  missing informed consent or unable to consent

          -  age &lt; 18 years

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claas P Naehle, MD</last_name>
    <phone>+41-71-494</phone>
    <phone_ext>6628</phone_ext>
    <email>claasphilip.naehle@kssg.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lukas Hechelhammer, MD</last_name>
    <phone>+41-71-494</phone>
    <phone_ext>6627</phone_ext>
    <email>lukas.hechelhammer@kssg.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Radiology and Nuclear Medicine</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claas P Naehle, MD</last_name>
      <phone>+41-71-494</phone>
      <phone_ext>6628</phone_ext>
      <email>claasphilip.naehle@kssg.ch</email>
    </contact>
    <contact_backup>
      <last_name>Lukas Hechelhammer, MD</last_name>
      <phone>+41-79-494</phone>
      <phone_ext>6627</phone_ext>
      <email>lukas.hechelhammer@kssg.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Dimitrios Tsinalis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurelia Schnyder, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2015</study_first_submitted>
  <study_first_submitted_qc>October 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2015</study_first_posted>
  <last_update_submitted>October 16, 2015</last_update_submitted>
  <last_update_submitted_qc>October 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cantonal Hospital of St. Gallen</investigator_affiliation>
    <investigator_full_name>Claas Philip NÃ¤hle</investigator_full_name>
    <investigator_title>Attending, Department of Radiology and Nuclear Medicine</investigator_title>
  </responsible_party>
  <keyword>Dialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

